In one paragraphArticle in Journal of the European Academy of Dermatology and Venereology : JEADV, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
Marion DescosDepartment of Dermatology and Reference Center for Rare Skin Diseases MAGEC-Sud Montpellier, Filière Maladies Rares Dermatologiques (FIMARAD), Saint-Eloi Hospital and Univ Montpellier, Montpellier, France.ORCID https://orcid.org/0009-0008-3386-8558 Smail Hadj-RabiaDepartment of Dermatology, Reference Center for Rare Skin Disorders in Children (MAGEC-Nord-Necker), Filière Maladies Rares Dermatologiques (FIMARAD), AP-HP, Necker-Enfants Malades Hospital, Paris Centre University, Paris, France.ORCID https://orcid.org/0000-0001-6801-7106 Stéphanie MalletDepartment of Dermatology and Center for Rare Skin Diseases MAGEC-Sud Marseille, Filière Maladie Rares Dermatologiques (FIMARAD), Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.ORCID https://orcid.org/0000-0003-2884-0645 Nathalia BellonDepartment of Dermatology, Reference Center for Rare Skin Disorders in Children (MAGEC-Nord-Necker), Filière Maladies Rares Dermatologiques (FIMARAD), AP-HP, Necker-Enfants Malades Hospital, Paris Centre University, Paris, France.ORCID https://orcid.org/0009-0001-0126-1128 Christine ChiaveriniDepartment of Dermatology, Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC-Sud), University Hospital Center (CHU) of Nice, Nice, France.ORCID https://orcid.org/0000-0002-6063-5409 Myriam MarqueDepartment of Dermatology, Caremeau Hospital, Nîmes University Hospital, Nîmes, France.
Justine PasteurDepartment of Dermatology, University Hospital Centre Clermont-Ferrand, Clermont-Ferrand, France.
Didier BessisDepartment of Dermatology and Reference Center for Rare Skin Diseases MAGEC-Sud Montpellier, Filière Maladies Rares Dermatologiques (FIMARAD), Saint-Eloi Hospital and Univ Montpellier, Montpellier, France.ORCID https://orcid.org/0000-0002-3815-5417 Groupe de Recherche de la Société Française de Dermatologie Pédiatrique
Funding
the French Ministry of Health
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
hyperpigmentationKITLGlinear and whorled nevoid hypermelanosismosaicism
Identifiers
PMID41885577
PMCPMC13505644
What OpenQuestion holds
Textmetadata
Read underepoch 390